Repligen (RGEN) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +24.97%. A quarter ago, it was expected that this drug developer would post earnings of $0.44 per share when it actually produced earnings of $0.49, delivering a surprise of +11.36%.Over the last four quarters, the compan ...